| Literature DB >> 35520475 |
Manuel Waltenspül1,2, Christoph Zindel1, Franziska C S Altorfer1, Stephan Wirth1, Jakob Ackermann1,3.
Abstract
Background: Magnetic resonance imaging (MRI) is commonly used for evaluation of ankle cartilage repair, yet its association with clinical outcome is controversial. This study analyzes the correlation between MRI and clinical outcome after cartilage repair of the talus including bone marrow stimulation, cell-based techniques, as well as restoration with allo- or autografting.Entities:
Keywords: T2 mapping; articular cartilage restoration; autologous chondrocyte implantation; bone marrow stimulation; cartilage repair; cell-based repair; clinical outcome; correlation; magnetic resonance imaging; magnetic resonance observation of cartilage repair tissue (MOCART); microfracture; morphological; osteochondral autograft transfer system
Year: 2022 PMID: 35520475 PMCID: PMC9067057 DOI: 10.1177/24730114221092021
Source DB: PubMed Journal: Foot Ankle Orthop ISSN: 2473-0114
Figure 1.Flowchart of the literature search.
Study and Patient Characteristics.
| Authors | Principle | Procedure | N | Mean Age, y | Mean Defect Size, cm2 | Follow-up, mo | MRI Protocol | MRI Score | Clinical Score |
|---|---|---|---|---|---|---|---|---|---|
| Battaglia et al
| MS | BMDCT | 20 | 28.1 | 0.147
| 24 | Foot
| MOCART | AOFAS |
| Becher et al
| MS | MF | 45 | 40 | 0.5-2 | 69.6 | Foot | MOCART | HSS |
| Becher et al
| MS | MF | 30 | 41 | 0.5-2 | 24 | Foot | Descriptive | HSS |
| Becher et al
| MS | MF | 15 | 37 | 0.87 | 94.8 | Foot, T2 mapping | MOCART | AOFAS, Hannover |
| Carlson et al
| MS | MF | 22 | 14.4 |
| 99.6 | Foot | MOCART | AOFAS |
| Casari et al
| MS | AMIC | 35 | 34.4 | 0,9 | 54 | Foot | MOCART | AOFAS, Tegner |
| D’Ambrosi et al
| MS | AMIC | 11 | 17.9 | 1.191 | 24 | Foot | Choi et al
| AOFAS, SF-12 PCS, SF-12 MCS |
| D’Ambrosi et al
| MS | AMIC | 37 | 34 | 1.53 | 24 | Foot | Choi et al
| AOFAS |
| Domayer et al
| MS | MF | 14 | 41.9 | 1.4 | 55 | Foot | MOCART | AOFAS, CIN |
| Giannini et al
| MS | BMDCT | 49 | 18.1 | 1.23 | 48 | Foot, T2 mapping | MOCART | AOFAS |
| Jurina et al
| MS | MF | 13 | 15 | n/a | 67 | Foot | MOCART | Berndt & Harty score, AOFAS, SANE question, Martin questionnaire |
| Kanatlı et al
| MS | AMIC | 40 | 38 | 2.5 | 33.8 | Foot | MOCART | AOFAS |
| Kim et al
| MS | MF & MSC | 50 | 46.1 | n/a | 21.9 | Foot | MOCART | AOFAS, Tegner |
| Kubosch et al
| MS | AMIC | 17 | 38.8 | 2.2 | 39.5 | Foot, T2 mapping | MOCART | AOFAS, FFI |
| Kuni et al
| MS | MF | 22 | 31 | 3.77 | 24 | Foot | Own criteria | AOFAS |
| Rehnitz et al
| MS | MF | 28 | 41.3 | n/a | 42 | Foot, T2 mapping, dGEMRIC | Own criteria | AOFAS |
| Sadlik et al
| MS | AMIC | 10 | 37 | n/a | 46.4 | Foot | MOCART | AOFAS |
| Shimozono et al
| MS | MF | 42 | 38.4 | 44.1 | 51.7 | Foot, T2 mapping, DWI | SCBH
| FAOS |
| Shimozono et al
| MS | MF | 43 | 38.4 | 0.46 | 48 | Foot | SCBH
| AOFAS |
| Tao et al
| MS | MF | 48 | 35.5 | 1.65 | 19.2 | Foot, T2 mapping | Own criteria | AOFAS |
| Usuelli et al
| MS | ACIC | 9 | 37.4 | 2.1 | 12 | Foot | MOCART | AOFAS |
| Valderrabano et al
| MS | AMIC | 26 | 33 | 1.61
| 31 | Foot | MOCART | AOFAS |
| Yang et al
| MS | MF | 25 | 39.24 | 0.84 | 43.2 | Foot | MOCART | FOAS, AOFAS, SF-36 |
| Ahn et al
| MS | MF | 64 | 40.1 | 0.858 | 35.7 | Foot | MOCART | AOFAS |
| Albano et al
| MS | AMIC | 16 | 42.6 | >1.5 | 30 | Foot | MOCART | AOFAS |
| Apprich et al
| MS& CB | MACI & MF | 20 | 31.7 | 1.09 | 53.8 | Foot, DWI | MOCART | AOFAS |
| Anders et al
| CB | MACI | 22 | 23.9 | 1.94 | 63.5 | Foot | MOCART | AOFAS |
| Aurich et al
| CB | MACI | 19 | 29.2 | 1.5 | 24.5 | Foot | MOCART | FFI, AOFAS, AAOS |
| Battaglia et al
| CB | ACI | 20 | 35 | 0.27 | 60 | Foot, T2 mapping | MOCART | AOFAS |
| Caumo et al
| CB | ACI | 41 | 35.2 |
| 12 | Foot | Own criteria | Tegner & Lysholm, AOFAS |
| DeSandis et al
| CB | JACI & BMAC | 46 | 37.6 |
| 24 | Foot | MOCART | FAOS, SF-12v2 |
| Lee et al
| CB | ACI | 38 | 35 | 1.94 | 24 | Foot | Anderson et al
| AOFAS, HSS |
| Lenz et al
| CB | MACI | 15 | 40 | 2.04 | 144 | Foot | MOCART | AOFAS, FAAM |
| Magnan et al
| CB | ACI | 30 | 28.9 | 2.36 | 45 | Foot | MOCART | AOFAS |
| Pagliazzi et al
| CB | ACI | 20 | 35 | 0.27 | 60 | Foot, T2 mapping, DWI | MOCART | AOFAS |
| Chen et al
| R | OAT
| 15 | 40.2 | 2.09 | 44.8 | Foot | MOCART | AOFAS, Ogilvie-Harris scale |
| Fraser et al
| R | OAT | 36 | 31 | 1.33 | 70.8 | Foot | Descriptive | AOFAS |
| Haraguchi et al
| R | OAT | 9 | 43.8 | n/a | 24 | Foot, T1ρ mapping | Own criteria | AOFAS |
| Hu et al
| R | OAT
| 17 | 37.3 | n/a | 32.6 | Foot, T2 mapping | MOCART | AOFAS |
| Imhoff et al
| R | OAT | 51 | 33 | 0.15 | 84 | Foot | Own criteria | AOFAS, Tegner |
| Nguyen et al
| R | OAT | 38 | 26 | 2.49 | 45 | Foot | MOCART | FAOS, RTS |
| Valderrabano et al
| R | OAT | 12 | 43 | 1.35 | 72 | Foot, gadolinium enhanced | Own criteria | AOFAS, Sports activity score, and own criteria |
| Woelfle et al
| R | OAT | 32 | 24.5 | n/a | 29 | Foot, T2 mapping | Descriptive | AOFAS, HSS |
Abbreviations: ACI, autologous chondrocyte implantation; ACIC, Autologous collagen induced chondrogenesis; AMIC, autologous matrix–induced chondrogenesis; AOFAS, American Orthopaedic Foot & Ankle Society score; BMAC, bone marrow aspirate concentrate; BMDCT, bone marrow–derived cell transplantation; CB, cell based; CIN, modified Cincinnati rating; DWI, diffusion weight imaging; FAAM, Foot and Ankle Ability Measure; FAOS, Foot and Ankle Outcome Score; FFI, Foot Function Index; HSS, Hannover Scoring System; JACI, juvenile allogenic chondrocyte implantation; MACI, matrix-induced autologous chondrocyte implantation; MCS, mental component summary; MF, microfracturing; MS, bone marrow stimulation; MOCART, magnetic resonance observation of cartilage repair tissue; MSC, mesenchymal stem cells; n/a, not available; R, cartilage restoration; OAT, osteochondral autograft/allograft transplantation; PCS, physical component summary; SANE, Single Assessment Numeric Evaluation; SCBH, subchondral bone health score; SF, Short Form Health Survey.
Defect size in cubic units.
Foot protocol including spin echo (SE), high signal intensity, fast SE sequences, turbo spin-echo, double-echo steady state, short-tau inversion recovery, proton-density fast-spin-echo, true fast imaging with steady state precession, and 3D-gradient echo sequences.
Autologous osteoperiosteal cylinder graft.
Study Quality.
| Authors | Design | Selection Bias | Attrition Bias | Detection Bias | Reporting Bias | Coleman
| LOE
|
|---|---|---|---|---|---|---|---|
| Ahn et al
| CS | Yes | No | No | No | 69 | IV |
| Albano et al
| CS | Yes | No | Yes | No | 55 | IV |
| Anders et al
| CS | No | No | No | No | 67 | IV |
| Apprich et al
| RCS | Yes | No | No | No | 42 | IV |
| Aurich et al
| CS | No | No | No | No | 67 | IV |
| Battaglia et al
| CS | No | No | No | No | 61 | IV |
| Battaglia et al
| CS | No | No | Yes | No | 57 | IV |
| Becher et al
| CS | Yes | Yes | Yes | No | 66 | IIb |
| Becher et al
| PCS | No | No | Yes | No | 70 | IV |
| Becher et al
| CS | Yes | No | No | No | 45 | IV |
| Carlson et al
| CS | Yes | Yes | No | No | 69 | IV |
| Casari et al
| CS | Yes | No | No | No | 53 | IV |
| Caumo et al
| CS | No | No | Yes | No | 33 | IV |
| Chen et al
| CS | Yes | No | No | No | 67 | IIb |
| D’Ambrosi et al
| CS | Yes | No | No | Yes | 52 | IV |
| D’Ambrosi et al
| CS | No | No | No | No | 59 | IV |
| DeSandis et al
| CS | Yes | Yes | Yes | Yes | 59 | IV |
| Domayer et al
| CS | Yes | No | Yes | No | 48 | IV |
| Fraser et al
| CS | No | No | Yes | Yes | 63 | IV |
| Giannini et al
| CS | Yes | Yes | Yes | No | 50 | IV |
| Haraguchi et al
| CS | Yes | No | Yes | No | 47 | IV |
| Hu et al
| CS | No | No | Yes | No | 66 | IV |
| Imhoff et al
| CS | Yes | No | No | No | 42 | IV |
| Jurina et al
| CS | Yes | Yes | No | Yes | 64 | IV |
| Kanatlı et al
| CS | No | No | No | No | 62 | IV |
| Kim et al
| RCS | Yes | No | No | No | 61 | IIIb |
| Kubosch et al
| CS | No | Yes | Yes | No | 61 | IV |
| Kuni et al
| CS | Yes | No | No | Yes | 47 | IV |
| Lee et al
| CS | Yes | Yes | Yes | No | 58 | IV |
| Lenz et al
| CS | Yes | No | No | No | 48 | IV |
| Magnan et al
| CS | Yes | No | Yes | No | 53 | IV |
| Nguyen et al
| CS | Yes | No | Yes | No | 63 | IV |
| Pagliazzi et al
| CS | Yes | No | Yes | No | 59 | IV |
| Rehnitz et al
| CS | Yes | No | No | No | 35 | IV |
| Sadlik et al
| CS | No | No | Yes | Yes | 61 | IV |
| Shimozono et al
| CS | Yes | Yes | Yes | No | 51 | IV |
| Shimozono et al
| CS | Yes | No | No | No | 70 | IV |
| Tao et al
| CS | Yes | Yes | Yes | No | 59 | IV |
| Usuelli et al
| CS | No | No | No | No | 65 | IV |
| Valderrabano et al
| CS | Yes | No | No | Yes | 46 | IV |
| Valderrabano et al
| CS | No | No | No | No | 60 | IV |
| Woelfle et al
| CS | Yes | Yes | No | No | 58 | IV |
| Yang et al
| CS | Yes | No | No | No | 69 | IV |
Abbreviations: CS, case series; PCS, prospective cohort study; RCS, retrospective cohort study.
Modified Coleman score.
Level of evidence following the Oxford Center for Evidence-Based Medicine.
Correlations Between the MRI and Clinical Outcome Scores.
| Author Classification | Composite | Filling | Integration | Surface | Structure | Signal Intensity | Subchondral Lamina | Subchondral Bone | Adhesions | Effusion | T2 Mapping | DWI | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOCART | |||||||||||||
| Ahn et al
| No | No | No | No | No | No | No | No | No | No |
|
| Yes
|
| Albano et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Anders et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Apprich et al
| No |
|
|
|
|
|
|
|
|
|
| No |
|
| Aurich et al
| No | Yes
| No | No | No | No | No | No | No | No |
|
|
|
| Battaglia et al
| No | No | No | No | No | No | No | No | No | No | No |
|
|
| Battaglia et al
| No | No | No | No | No | Yesd | No | No | No | No | Yesc |
|
|
| Carlson et al
| No | No | No | No | No | No | No | No | No | No |
|
|
|
| Casari et al
| No | No | No | No | No | No | No | No | No | No |
|
|
|
| Chen et al
| Yes
|
|
|
|
|
|
|
|
|
|
|
|
|
| DeSandis et al
| Yes
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hu et al
| Yes
|
|
|
|
|
|
|
|
|
|
|
|
|
| Jurina et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Kanatli et al
| No | Yes
| No | No | No | No | No | No | No | No |
|
|
|
| Kim et al
| Yes
|
|
|
|
|
|
|
|
|
|
|
|
|
| Kubosch et al
| Yes
|
|
|
|
|
|
|
|
|
| No |
|
|
| Lenz et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Magnan et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Nguyen et al
| Yes
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pagliazzi et al
| No | Yes
| No | No | No | No | No | No | No | No | Yes
|
|
|
| Sadlik et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Usuelli et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Valderrabano et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Yang et al
| Yes
|
|
|
|
|
|
|
|
|
|
|
|
|
| Choi | |||||||||||||
| D’Ambrosi et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| D’Ambrosi et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| Own criteria | |||||||||||||
| Becher et al
|
| No | Yes
|
|
|
|
|
|
| Yesd |
|
|
|
| Becher et al
|
| No |
|
|
|
|
| No |
|
|
|
|
|
| Becher et al
| No |
|
|
|
|
|
|
|
|
| No |
|
|
| Caumo et al
|
| Yes
| Yes
|
|
| Yes
| Yes
| Yes
|
|
|
|
|
|
| Fraser et al
|
|
| No | No |
|
|
| No |
|
|
|
|
|
| Giannini et al
|
|
|
|
|
|
|
|
|
|
| No |
|
|
| Imhoff et al
|
|
|
| Yes
|
|
|
|
|
|
|
|
|
|
| Kuni et al
|
| No | No |
|
|
|
| Yes
|
| No |
|
|
|
| Rehnitz et al
|
|
|
|
|
|
|
|
|
|
| Yes
| No |
|
| Tao et al
|
| Yes
|
|
|
|
|
| Yes
|
|
| Yes
| No |
|
| Valderrabano et al
| Yes
|
|
|
|
|
|
|
|
|
|
|
|
|
| Woelfle et al
| No |
|
| No | No | No |
| No |
| No |
|
|
|
| Anderson | |||||||||||||
| Lee et al
| No |
|
|
|
|
|
|
|
|
|
|
|
|
| SCBH Score | |||||||||||||
| Shimozono et al
| Yesd |
|
|
|
|
|
|
|
|
|
|
|
|
| Shimozono et al
| Yesd |
|
|
|
|
|
|
|
|
|
|
|
|
| T mapping | |||||||||||||
| Domayer et al
|
|
|
|
|
|
|
|
|
|
| No |
|
|
| Haraguchi et al
|
|
|
|
|
|
|
|
|
|
| Yes
|
|
|
Abbreviations: LOE, level of evidence; MOCART, magnetic resonance observation of cartilage repair tissue; SCBH, subchondral bone health score.
Numbers provided represent exact correlation coefficients; if no coefficients were given, “yes” or “no” was used to indicate that articles found or did not find a correlation between radiologic and clinical outcome, respectively. –, not applicable.
P value unavailable.
P < .05.
P < .01.